Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria. - Test2 - elhamkhani - TriplyDB

Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria.

Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria.

http://www.wikidata.org/entity/Q33881765

about

Clinical utilities and biological characteristics of melanoma sentinel lymph nodes Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition)Micrometastatic cancer cells in lymph nodes, bone marrow, and blood: Clinical significance and biologic implications Progression of cutaneous melanoma: implications for treatment Data set for pathology reporting of cutaneous invasive melanoma: recommendations from the international collaboration on cancer reporting (ICCR).Prognosis of sentinel node staged patients with primary cutaneous melanoma Prognosis in patients with sentinel node-positive melanoma without immediate completion lymph node dissection.Sentinel lymph node biopsy in melanoma: our 8-year clinical experience in a single French institute (2002-2009)Stage-specific prognostic biomarkers in melanoma Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.The impact of primary melanoma thickness and microscopic tumor burden in sentinel lymph nodes on melanoma patient survival.New developments in melanoma: utility of ultrasound imaging (initial staging, follow-up and pre-SLNB).Advances in sentinel lymph node mapping for patients with melanoma.Surgeons' opinions on lymphadenectomy in melanoma patients with positive sentinel nodes: a worldwide web-based survey.Surgical treatment of melanoma patients with early sentinel node involvement.Melanoma metastasis: new concepts and evolving paradigms.Tissue prognostic biomarkers in primary cutaneous melanoma.Sentinel lymph node biopsy in melanoma: controversies and current guidelines.Molecular markers to complement sentinel node status in predicting survival in patients with high-risk locally invasive melanoma.Is the non-sentinel lymph node compartment the next site for melanoma progression from the sentinel lymph node compartment in the regional nodal basin?Timing of completion lymphadenectomy after positive sentinel node biopsy in patients with melanoma.Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy Detailed pathological examination of completion node dissection specimens and outcome in melanoma patients with minimal (<0.1 mm) sentinel lymph node metastases.Sentinel lymph node biopsy staging for cutaneous malignant melanoma of the head and neck.Health-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trial.Guidelines for biomarker testing in metastatic melanoma: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.Sentinel node metastasis mitotic rate (SN-MMR) as a prognostic indicator of rapidly progressing disease in patients with sentinel node-positive melanomas.Optimal extent of completion lymphadenectomy for patients with melanoma and a positive sentinel node in the groin.Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.Treatment and outcomes of melanoma in Asia: Results from the National Cancer Centre Singapore.Comment: Detailed Pathologic Examination of Completion Node Dissection Specimens and Outcome for Melanoma Patients with Minimal (< 0.1 mm) Sentinel Lymph Node Metastases.Frozen section analysis of SLNs in trunk and extremity melanoma has a high false negative rate but can spare some patients a second operation.[Malignant head and neck melanoma: Part 2: Therapy].Prognostic value of BRAF(V⁶⁰⁰) mutations in melanoma patients after resection of metastatic lymph nodes.Completion lymphadenectomy for sentinel node positive cutaneous head & neck melanoma.Interferon is associated with improved survival for node-positive cutaneous melanoma: a single-institution experience

P2860

Q26747723-380C23A1-784A-40F5-B024-6851E218AD75 Q26770492-7F9CDF58-724E-486D-9588-7EDDF55EC5F1 Q26996059-8DA97AF5-3B6E-464F-BC70-C9BBE1AFEEE8 Q27001734-BC7DCC12-F853-4EB0-9A60-2648B6D8D92B Q30669529-6B063E8A-EA42-4A6D-A4CB-B2DB072BED4F Q34140267-59DF702C-9045-4E15-ADBC-18698465C599 Q34409481-87FD33AE-3CBE-41BC-BA67-167627E88D74 Q34507667-AC8FF6A6-3746-42CC-A9B0-60614F974555 Q35551970-9D0CCC07-C2EE-4F57-A9D8-9524F227EFFA Q37417271-D13A68E3-CC56-49A6-9A85-68EB58E97AC2 Q37944487-71070A48-FF99-4BDE-84C3-EB0F246064EC Q37952237-827F465F-40BF-487D-A989-399EBBBEA4BD Q37984125-DEE5C4B9-6C31-45E0-8F21-32EDC5955D68 Q38027028-EE5C3299-E251-4324-9729-A3F68B268E13 Q38027415-4E49B6D1-17DC-4689-92E8-72A78CCB7897 Q38111220-1B1CE060-BCB4-4D21-8BEF-00F6317083E8 Q38184377-C154E17B-5F93-4EF1-BBED-B715D0995C3F Q38190113-833401FA-620E-4F0D-98ED-DEDAB316A95C Q38381558-24A5DCA0-628F-4638-AF0D-E494FE887375 Q38683103-ED343857-08BF-4A04-91C5-C63C592EEFA4 Q38951984-D0F7E8A1-A411-4F87-9A7C-3E9B757F1313 Q39311439-8BB0C889-B913-42B7-9945-D781CF07A123 Q40922293-AA3EFFAC-5C80-4FC2-B3DA-6FC2CC86B150 Q40976748-92A8FA0E-0703-414A-AD25-6B0FA9906F77 Q42262252-18C50232-D61A-4E4B-9DFD-3A509D5C1FD9 Q43796093-6651A96D-A58E-47E3-A975-73FFA2F0BC43 Q47611324-891B8DB1-5A5C-4731-BC4E-DA4890D58593 Q47669815-433EF4E6-48EC-4E64-95BD-31092D56B7E9 Q47803820-2DDED327-0CF9-4ED8-93CD-6CE2529843B0 Q48155759-D12D337A-7541-4AD5-8C68-16BBEAF6C61D Q50108588-C1F1EBE6-6FF0-4481-B2FB-97594E1F7CE2 Q52980009-9E1CBDB7-425E-4272-8E7D-4A785A38EF4B Q54256327-513292D2-4D27-464B-ADDC-2CAA1FAA307B Q54301896-B2A8C5A0-F0CD-4E4F-ABD4-62E41C451D8B Q55248566-733FF2F5-A6E3-487E-A09C-711B16E329A8 Q58747512-4C9DF191-D131-461A-99EB-CE4578149264

P2860

Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria.

http://www.wikidata.org/entity/Q33881765

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Prognosis in patients with sen ...... and Dewar topography criteria.

@ast

Prognosis in patients with sen ...... and Dewar topography criteria.

@en

type

label

Prognosis in patients with sen ...... and Dewar topography criteria.

@ast

Prognosis in patients with sen ...... and Dewar topography criteria.

@en

prefLabel

Prognosis in patients with sen ...... and Dewar topography criteria.

@ast

Prognosis in patients with sen ...... and Dewar topography criteria.

@en

P1433

Q33881765-D1D2A3CD-25D7-40D0-BCB4-4DC7D881E495

P1476

Q33881765-EF2C8AC2-53C0-4B5D-8637-2ADB751A2C59

P2093

Q33881765-0BA30172-B78D-4498-9B48-37E9A2160BC6

Q33881765-0F793F59-3C9C-4C63-86B1-3A99DB528C23

Q33881765-16026DC3-DBA2-429C-8013-AC919242A2FF

Q33881765-25D5A723-33C8-4008-B93D-96F185856596

Q33881765-3B42497C-6114-4078-861C-14BC1DBF38C7

Q33881765-8FC60715-8C5E-4833-B89B-2434BF5A395C

Q33881765-8FF67692-E2BA-4D32-AFEB-6E1A36FE9C68

Q33881765-92974090-841D-4701-8B91-C501A00387A7

Q33881765-9ABC091F-CB35-4681-B272-E0692EEBFA10

Q33881765-BC281DCF-2553-46FF-BA0F-8E9553E7F16F

P304

Q33881765-263A3CBE-33C0-45B9-B9AB-D40B0EC338BD

P31

Q33881765-113E2D61-7CA9-4315-AC08-A26F6C97F606

P356

Q33881765-E4EE15A5-E6C4-4FC9-9702-64CCA7A20908

P407

Q33881765-ED6BC385-4E6A-4772-941C-C59C81EA1868

P433

Q33881765-2B5599F7-9BC5-416D-98B2-F5B531C21DB0

P478

Q33881765-A009F721-DCA0-4942-9F31-90EFAAE02969

P50

Q33881765-24F6BF8E-4F76-4039-B6A3-E496E91F9E0F

Q33881765-8E008F90-EC2B-4642-ABFA-5246277AE41E

Q33881765-F92515B6-7D00-4073-A0F4-FA8784E82B62

P577

Q33881765-F1033AD4-1E86-4986-87AD-B213D876D682

P698

Q33881765-697A8457-CB1F-4C50-9DC0-E9142CF59952

P356

JCO.2010.31.6760

P1433

Journal of Clinical Oncology

P1476

Prognosis in patients with sen ...... and Dewar topography criteria.

@en

P2093

Alain Spatz

http://www.w3.org/2001/XMLSchema#string

Alessandro Testori

http://www.w3.org/2001/XMLSchema#string

Alexander C J van Akkooi

http://www.w3.org/2001/XMLSchema#string

Alexander M M Eggermont

http://www.w3.org/2001/XMLSchema#string

Angana Mitra

http://www.w3.org/2001/XMLSchema#string

Augustinus P T van der Ploeg

http://www.w3.org/2001/XMLSchema#string

Christiane A Voit

http://www.w3.org/2001/XMLSchema#string

Cornelis Verhoef

http://www.w3.org/2001/XMLSchema#string

Francesco Cataldo

http://www.w3.org/2001/XMLSchema#string

Harald J Hoekstra

http://www.w3.org/2001/XMLSchema#string

P304

2206-2214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2010.31.6760

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Alexander Eggermont

Caroline Robert

Piotr Rutkowski

P577

2011-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21519012

http://www.w3.org/2001/XMLSchema#string